INTELLIGENT BIO SOLUTIONS INC.
For the period ended Jun 30, 2026. Filed Aug 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Aug 19, 2026
INBS$2.29+16.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
| Additional · Other · Non- · Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Common stock · Treasury stock · paid-in · Accumulated · comprehensive · controlling · shareholders’ | |||||||||
| Shares | Amount | Shares | Amount | capital | deficit | income (loss) | interest | equity | |
| Balance, June 30, 2025* | 732,327 | $7,324 | (12) | (1) | 65,849,822 | $(62,533,065) | $(327,944) | $(182,312) | $2,813,824 |
| Issuance of restricted stock to vendors | 15,434 | 154 | - | - | 97,421 | - | - | - | 97,575 |
| Issuance of common stock, net of issuance costs At-the-Market Offerings | 357,835 | 3,578 | - | - | 1,768,159 | - | - | - | 1,771,737 |
| Common stock issued for warrants exercised, net of issuance costs | 1,579,007 | 15,790 | - | - | 4,268,122 | - | - | - | 4,283,912 |
| Issuance of common stock, net of issuance costs | 105,000 | 1,050 | - | - | 8,912,009 | 8,913,059 | |||
| Issuance of restricted shares to employees | 116,000 | 1,160 | - | - | (1,160) | - | - | - | - |
| Share based compensation expense | - | - | - | - | 97,633 | - | - | - | 97,633 |
| Foreign currency translation adjustment | - | - | - | - | - | - | (218,242) | - | (218,242) |
| Net loss | - | - | - | - | - | (12,430,975) | - | (37,697) | (12,468,672) |
| Balance, June 30, 2026 | 2,905,603 | $29,056 | (12) | (1) | 80,992,006 | $(74,964,040) | $(546,186) | $(220,009) | $5,290,826 |
| Additional · Other · Non- · Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Common stock · Treasury stock · paid-in · Accumulated · comprehensive · controlling · shareholders’ | |||||||||
| Shares | Amount | Shares | Amount | capital | deficit | income (loss) | interest | equity | |
| Balance, June 30, 2024* | 345,600 | $3,456 | (12) | $(1) | 61,002,841 | $(51,964,332) | $(712,614) | $(146,159) | $8,183,191 |
| Issuance of restricted stock to vendors | 3,366 | 34 | - | - | 47,966 | - | - | - | 48,000 |
| Issuance of common stock, net of issuance costs At-the-Market Offerings | 293,466 | 2,935 | - | - | 4,601,930 | - | - | - | 4,604,865 |
| Common stock issued for warrants exercised, net of issuance costs | 79,945 | 799 | - | - | 7,140 | - | - | - | 7,939 |
| Issuance of restricted shares to employees | 9,950 | 100 | - | - | 189,945 | - | - | - | 190,045 |
| Foreign currency translation adjustment | - | - | - | - | - | - | 384,670 | - | 384,670 |
| Net loss | - | - | - | - | - | (10,568,733) | - | (36,153) | (10,604,886) |
| Balance, June 30, 2025 | 732,327 | 7,324 | (12) | (1) | 65,849,822 | (62,533,065) | (327,944) | (182,312) | 2,813,824 |
| * | Common stock and per share amounts have been retroactively adjusted to reflect a 1-for-10 reverse stock split effected on December 15, 2025, throughout the consolidated financial statements unless otherwise stated. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.